Hca Florida Westside Hospital

CLIA Laboratory Citation Details

2
Total Citations
25
Total Deficiencyies
25
Unique D-Tags
CMS Certification Number 10D0285781
Address 8201 W Broward Blvd, Plantation, FL, 33324
City Plantation
State FL
Zip Code33324
Phone(954) 473-6600

Citation History (2 surveys)

Survey - April 16, 2021

Survey Type: Complaint

Survey Event ID: UXKI12

Deficiency Tags: D1001 D5293 D5411 D5429 D5209 D5305 D5423 D5781

Summary:

Summary Statement of Deficiencies D1001 CERTIFICATE OF WAIVER TESTS CFR(s): 493.15(e) Laboratories eligible for a certificate of waiver must-- (1) Follow manufacturers' instructions for performing the test; and (2) Meet the requirements in subpart B, Certificate of Waiver, of this part. This STANDARD is not met as evidenced by: Based on record review, observation, and interview with Technical Supervisor B the laboratory failed to follow manufacturer's instruction for labeling quality control and test strips for the glucometers located in the Emergency Department. Findings Included: Review of the manufacturer's instructions (MI) for the Nova StatStrip blood glucose monitoring system state that "Controls are valid for 90 days after opened, not to exceed the manufacturer's expiration date. Record the new expiration date on each vial." It also stated that "Glucose test strips are valid for 180 days after opened, not to exceed the manufacturer's expiration date. Record the open date and new expiration date on the test vial." Tour of the Emergency Department on 04/15/2021 at 11:45 AM revealed 2 bottles of test strips (Lot#0320265249, Expiration 09/21/2022). One bottle did not have an open or discard date and the second bottle did not have a discard date. There were 2 bottles of low level control (Lot#0420095301 Expiration 10/04/2022) both had a discard date of 03/06/2022 and a high level control (Lot#0420016303 Expiration 07/16/2022) that had a discard date of 03/06/2022. Both of these dates would exceed the MI of only being valid for 90 days after opening. Interview on 04/15 /2021 at 11:45 AM Technical Supervisor B confirmed that the controls and strips were not labeled per the MI. D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 6 -- and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory failed to follow their Training and Competency policy for the 2020 annual competency assessments for 4 (A, B, C, E) of 6 (A, B, C, D, E, F) Testing Personnel reviewed. Findings included: Review of the Training and Competency Procedure, section VI Competency Assessment, F, #2 notes "Monitoring records of reported information (paper or electronic) which must include the following: Name of test or task and date of records." Review of the competency assessment showed for the moderate complexity testing performed in patient care areas of the hospital, 4 (A, B, C, E) Testing Personnel's competency assessments failed to indicate which tests the Testing Personnel were being evaluated on. During an interview on 04/15/2021 at 4:35 PM, the Technical Supervisor B stated the annual competency evaluations did not indicate which tests the Testing Personnel were being evaluated on. D5293 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(b)(c) (b) The general laboratory systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 5, 2020

Survey Type: Complaint

Survey Event ID: UXKI11

Deficiency Tags: D0000 D5311 D5401 D5407 D5821 D6063 D6076 D6102 D6171 D5300 D5400 D5403 D5800 D6029 D6065 D6082 D6168

Summary:

Summary Statement of Deficiencies D0000 An unannounced complaint survey #2020015973 was conducted on 11/03/20-11/05 /20 at Westside Regional Medical Center. The laboratory was not in compliance with 42 CFR Part 493, requirements for Clinical Laboratories. Based on the survey findings an Immediate Jeopardy situation was identified and the laboratory was notified at 11:40 AM on 11/05/20. Laboratory testing personnel used a mislabeled tube of blood to perform ABO blood group/ Rhesus blood group (ABO/Rh) testing, Type and Screen antibody identification, and Crossmatch for one unit of Red Blood Cells (RBC's) (D5300). Laboratory testing personnel failed to follow the procedures "BB 82 Patient Retype" for confirmatory ABO/Rh typing (D5400). The following Conditions were not met: D5300 - 493.1240 - Preanalytic Systems D5400 - 493.1250 - Analytic Systems D5800 - 493.1290 - Postanalytic Systems D6063 - 493.1421 - Testing Personnel D6076 - 493.1441 - Laboratory Director D6168 - 493.1487 - Testing Personnel D5300 PREANALYTIC SYSTEMS CFR(s): 493.1240 Each laboratory that performs nonwaived testing must meet the applicable preanalytic system(s) requirements in 493.1241 and 493.1242, unless HHS approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing. The laboratory must monitor and evaluate the overall quality of the preanalytic systems and correct identified problems as specified in 493. 1249 for each specialty and subspecialty of testing performed. This CONDITION is not met as evidenced by: Based on record review and interview, the laboratory's quality assessment program failed to monitor and evaluate the overall quality of the preanalytic system and correct identified problems. Findings: Cross Reference D5311: Based on record review and interview, the laboratory personnel failed to follow the procedure manual. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 10 -- D5311 SPECIMEN SUBMISSION, HANDLING, AND REFERRAL CFR(s): 493.1242(a) The laboratory must establish and follow written policies and procedures for each of the following, if applicable: (1) Patient preparation. (2) Specimen collection. (3) Specimen labeling, including patient name or unique patient identifier and, when appropriate, specimen source. (4) Specimen storage and preservation. (5) Conditions for specimen transportation. (6) Specimen processing. (7) Specimen acceptability and rejection. (8) Specimen referral. This STANDARD is not met as evidenced by: Based on record review and interview, the laboratory personnel failed to follow the procedure manual. Findings: Review of the Root Cause Analysis timeline states the technologist failed to perform the two patient identifier step. Review of the timeline showed on "4/23/20 17:44 Blood Bank (BB) technologist received order for "Type and Cross" (TC) 1 unit of PRBC (Packed Red Blood Cells). The patient had no previous blood bank history in Meditech. The Technologist checked the extra rack to see if a pink top tube was already in the lab. The BB technologist did not request a second specimen for confirmation since the original tube was collected using MobiLab. She discovered the label was missing the barcode, and the Echo (blood bank analyzer) instrument would not be able to read the order information, the BB technologist proceeded to print another label for the TC and placed it on the tube obstructing the original label which prevented the two patient identifier step." Review of the Discipline /

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access